# SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease

Study · id `cardio:ct-nct02544204` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02544204](<https://clinicaltrials.gov/study/NCT02544204>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02544204

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT02544204. Randomized; double masking; primary purpose treatment. Start 2015-11 (registry gives no type); primary completion 2017-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT02544204, source copy `cardio:ctgov-nct02544204-2016-11-02`, retrieved 2026-10-31)
- Start date: 2015-11 (registry gives no type) (ClinicalTrials.gov record NCT02544204, source copy `cardio:ctgov-nct02544204-2016-11-02`, retrieved 2026-10-31)
- Primary completion: 2017-09 (anticipated) (ClinicalTrials.gov record NCT02544204, source copy `cardio:ctgov-nct02544204-2016-11-02`, retrieved 2026-10-31)
- Completion: 2017-11 (anticipated) (ClinicalTrials.gov record NCT02544204, source copy `cardio:ctgov-nct02544204-2016-11-02`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT02544204, source copy `cardio:ctgov-nct02544204-2016-11-02`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02544204-2016-11-02`, retrieved 2026-10-31)

## The registry's words

- Brief title: SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease
- Acronym: STOP-PAD
- Condition: Peripheral Arterial Disease
- Intervention (Biological): JVS-100
- Intervention (Biological): Placebo
- Lead sponsor: Juventas Therapeutics, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: SDF-1 plasmid treatment for patients with peripheral artery disease (STOP-PAD): Randomized, double-blind, placebo-controlled clinical trial (`cardio:pubmed-30786835`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Stromal Cell-Derived Factor-1 Plasmid Treatment for Patients With Peripheral Artery Disease (STOP-PAD) Trial: Six-Month Results (`cardio:pubmed-32419594`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 8833358c9a12f885f4a2011b46d601eb0ccba1220e33881e8b1e134bdd6d5270
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
